A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa

Updated on: February 18,2024

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa

Updated on:February 18,2024

New possibilities for treating intractable brain tumors unveiled

New possibilities for treating intractable brain tumors unveiledbyThe Korea Advanced Institute of Science and Technology (KAIST)Overview of the study on the enhanced response to anti-PD-1 therap

Updated on: December 01,2024

New possibilities for treating intractable brain tumors unveiled

New possibilities for treating intractable brain tumors unveiledbyThe Korea Advanced Institute of Science and Technology (KAIST)Overview of the study on the enhanced response to anti-PD-1 therap

Updated on:December 01,2024

New discovery can help detect brain tumors

byUniversity of TurkuFluorine-18-labelled folate PET/CT 3D fusion image of a rat subject with a glioma visible in the central region of the brain. Credit: Maxwell MinerFolate-based radiopharmace

Updated on: January 13,2024

New discovery can help detect brain tumors

byUniversity of TurkuFluorine-18-labelled folate PET/CT 3D fusion image of a rat subject with a glioma visible in the central region of the brain. Credit: Maxwell MinerFolate-based radiopharmace

Updated on:January 13,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on: May 09,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on:May 09,2024

One test to diagnose them all: Researchers exploit cancers' unique DNA signature

by Abu Sina, Laura G. Carrascosa And Matt Trau,The ConversationCredit: AI-generated imageResearchers have developed a test that could be used to diagnose all cancers. It is based on a unique DNA

Updated on: May 07,2024

One test to diagnose them all: Researchers exploit cancers' unique DNA signature

by Abu Sina, Laura G. Carrascosa And Matt Trau,The ConversationCredit: AI-generated imageResearchers have developed a test that could be used to diagnose all cancers. It is based on a unique DNA

Updated on:May 07,2024

Study points to practice-changing care for patients with refractory metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainJosep Tabernero, Director of the Vall d'Hebron Institute of Oncology (VHIO), presented data from the international phase

Updated on: February 23,2024

Study points to practice-changing care for patients with refractory metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainJosep Tabernero, Director of the Vall d'Hebron Institute of Oncology (VHIO), presented data from the international phase

Updated on:February 23,2024

Liquid biopsy blood test shows superior sensitivity in detecting HPV-associated head and neck cancers

Updated on: June 14,2025

Liquid biopsy blood test shows superior sensitivity in detecting HPV-associated head and neck cancers

Updated on:June 14,2025

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient

Updated on: April 14,2024

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient

Updated on:April 14,2024

A new way to predict complications after larynx cancer surgery

by Nicole Fawcett,University of MichiganRebecca Hoesli, M.D., and Matthew Spector, M.D., evaluate an image from the study Credit: University of Michigan Rogel Cancer CenterA technique that illum

Updated on: May 17,2024

A new way to predict complications after larynx cancer surgery

by Nicole Fawcett,University of MichiganRebecca Hoesli, M.D., and Matthew Spector, M.D., evaluate an image from the study Credit: University of Michigan Rogel Cancer CenterA technique that illum

Updated on:May 17,2024

Study identifies how cancer-causing gene regulates genetic variation in prostate cancer

by Queen Mary, University of LondonGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111404Researchers from Barts Cancer Institute (BCI) at Queen Mary Universi

Updated on: January 30,2024

Study identifies how cancer-causing gene regulates genetic variation in prostate cancer

by Queen Mary, University of LondonGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111404Researchers from Barts Cancer Institute (BCI) at Queen Mary Universi

Updated on:January 30,2024

Differences found in how doctors, caregivers and patients report side effects of cancer therapy

by Children's Hospital Los AngelesCredit: CC0 Public DomainA recent study reveals differences in how symptom toxicity is reported for children receiving cancer treatment in clinical trials. D

Updated on: February 03,2024

Differences found in how doctors, caregivers and patients report side effects of cancer therapy

by Children's Hospital Los AngelesCredit: CC0 Public DomainA recent study reveals differences in how symptom toxicity is reported for children receiving cancer treatment in clinical trials. D

Updated on:February 03,2024

Researchers review the role of integrins in human hepatocellular carcinoma

by Cactus CommunicationsIn a recent review article, researchers summarize the roles integrins play in cancer cells and the current status of anti-integrin therapy for cancer. As a family of unique tra

Updated on: January 30,2024

Researchers review the role of integrins in human hepatocellular carcinoma

by Cactus CommunicationsIn a recent review article, researchers summarize the roles integrins play in cancer cells and the current status of anti-integrin therapy for cancer. As a family of unique tra

Updated on:January 30,2024